Literature DB >> 23652004

A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases.

Kyota Fujita1, Yoko Nakamura1, Tsutomu Oka1, Hikaru Ito1, Takuya Tamura1, Kazuhiko Tagawa1, Toshikazu Sasabe1, Asuka Katsuta1,2, Kazumi Motoki1, Hiroki Shiwaku1, Masaki Sone1,2, Chisato Yoshida1, Masahisa Katsuno3, Yoshinobu Eishi4, Miho Murata5, J Paul Taylor6, Erich E Wanker7, Kazuteru Kono8, Satoshi Tashiro8, Gen Sobue3, Albert R La Spada9, Hitoshi Okazawa1,10.   

Abstract

It is hypothesized that a common underlying mechanism links multiple neurodegenerative disorders. Here we show that transitional endoplasmic reticulum ATPase (TERA)/valosin-containing protein (VCP)/p97 directly binds to multiple polyglutamine disease proteins (huntingtin, ataxin-1, ataxin-7 and androgen receptor) via polyglutamine sequence. Although normal and mutant polyglutamine proteins interact with TERA/VCP/p97, only mutant proteins affect dynamism of TERA/VCP/p97. Among multiple functions of TERA/VCP/p97, we reveal that functional defect of TERA/VCP/p97 in DNA double-stranded break repair is critical for the pathology of neurons in which TERA/VCP/p97 is located dominantly in the nucleus in vivo. Mutant polyglutamine proteins impair accumulation of TERA/VCP/p97 and interaction of related double-stranded break repair proteins, finally causing the increase of unrepaired double-stranded break. Consistently, the recovery of lifespan in polyglutamine disease fly models by TERA/VCP/p97 corresponds well to the improvement of double-stranded break in neurons. Taken together, our results provide a novel common pathomechanism in multiple polyglutamine diseases that is mediated by DNA repair function of TERA/VCP/p97.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652004      PMCID: PMC4543262          DOI: 10.1038/ncomms2828

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  54 in total

1.  VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.

Authors:  M Hirabayashi; K Inoue; K Tanaka; K Nakadate; Y Ohsawa; Y Kamei; A H Popiel; A Sinohara; A Iwamatsu; Y Kimura; Y Uchiyama; S Hori; A Kakizuka
Journal:  Cell Death Differ       Date:  2001-10       Impact factor: 15.828

2.  Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.

Authors:  Sara K Custer; Manuela Neumann; Hongbo Lu; Alexander C Wright; J Paul Taylor
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

3.  Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.

Authors:  Yi Hu; Vanita Chopra; Raman Chopra; Joseph J Locascio; Zhixiang Liao; Hongliu Ding; Bin Zheng; Wayne R Matson; Robert J Ferrante; H Diana Rosas; Steven M Hersch; Clemens R Scherzer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

4.  A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model.

Authors:  Andrey S Tsvetkov; Jason Miller; Montserrat Arrasate; Jinny S Wong; Michael A Pleiss; Steven Finkbeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-10       Impact factor: 11.205

5.  A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

Authors:  Janghoo Lim; Tong Hao; Chad Shaw; Akash J Patel; Gábor Szabó; Jean-François Rual; C Joseph Fisk; Ning Li; Alex Smolyar; David E Hill; Albert-László Barabási; Marc Vidal; Huda Y Zoghbi
Journal:  Cell       Date:  2006-05-19       Impact factor: 41.582

6.  Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.

Authors:  A R La Spada; Y H Fu; B L Sopher; R T Libby; X Wang; L Y Li; D D Einum; J Huang; D E Possin; A C Smith; R A Martinez; K L Koszdin; P M Treuting; C B Ware; J B Hurley; L J Ptácek; S Chen
Journal:  Neuron       Date:  2001-09-27       Impact factor: 17.173

7.  Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression.

Authors:  Masaaki Koike; Junpei Fukushi; Yuzuru Ichinohe; Naoki Higashimae; Masahiko Fujishiro; Chiyomi Sasaki; Masahiro Yamaguchi; Toshiki Uchihara; Saburo Yagishita; Hiroshi Ohizumi; Seiji Hori; Akira Kakizuka
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

8.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

9.  Polar amino acid-rich sequences bind to polyglutamine tracts.

Authors:  I Imafuku; M Waragai; S Takeuchi; I Kanazawa; M Kawabata; M M Mouradian; H Okazawa
Journal:  Biochem Biophys Res Commun       Date:  1998-12-09       Impact factor: 3.575

10.  Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.

Authors:  Yaohui Chai; Jianqiang Shao; Victor M Miller; Aislinn Williams; Henry L Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  31 in total

1.  DNA repair: A unifying mechanism in neurodegeneration.

Authors:  Christopher A Ross; Ray Truant
Journal:  Nature       Date:  2016-12-21       Impact factor: 49.962

2.  Identification of Novel SCIRR69-Interacting Proteins During ER Stress Using SILAC-Immunoprecipitation Quantitative Proteomics Approach.

Authors:  Yujian Chen; Yong Liu; Shide Lin; Shuguang Yang; Haiping Que; Shaojun Liu
Journal:  Neuromolecular Med       Date:  2016-08-03       Impact factor: 3.843

3.  Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4.

Authors:  Nan Ding; Qianzheng Zhu
Journal:  Transl Cancer Res       Date:  2018-04       Impact factor: 1.241

4.  Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.

Authors:  Hui Yang; Shuai Liu; Wen-Tian He; Jian Zhao; Lei-Lei Jiang; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

Review 5.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

6.  Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.

Authors:  Tao Wang; Wangchao Xu; Meiling Qin; Yi Yang; Puhua Bao; Fuxiao Shen; Zhenlin Zhang; Jin Xu
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

7.  CAG RNAs induce DNA damage and apoptosis by silencing NUDT16 expression in polyglutamine degeneration.

Authors:  Shaohong Peng; Pei Guo; Xiao Lin; Ying An; Kong Hung Sze; Matthew Ho Yan Lau; Zhefan Stephen Chen; Qianwen Wang; Wen Li; Jacquelyne Ka-Li Sun; Sum Yi Ma; Ting-Fung Chan; Kwok-Fai Lau; Jacky Chi Ki Ngo; Kin Ming Kwan; Chun-Ho Wong; Sik Lok Lam; Steven C Zimmerman; Tiziano Tuccinardi; Zhong Zuo; Ho Yu Au-Yeung; Hei-Man Chow; Ho Yin Edwin Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

8.  Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.

Authors:  Xiao-Jing Li; Yuan-Yuan Zhang; Yu-Hua Fu; Hao Zhang; He-Xuan Li; Quan-Fu Li; Hai-Ling Li; Ren-Ke Tan; Chen-Xiao Jiang; Wei Jiang; Zeng-Xia Li; Cheng Luo; Bo-Xun Lu; Yong-Jun Dang
Journal:  Acta Pharmacol Sin       Date:  2021-01-25       Impact factor: 7.169

9.  HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice.

Authors:  Hikaru Ito; Kyota Fujita; Kazuhiko Tagawa; Xigui Chen; Hidenori Homma; Toshikazu Sasabe; Jun Shimizu; Shigeomi Shimizu; Takuya Tamura; Shin-ichi Muramatsu; Hitoshi Okazawa
Journal:  EMBO Mol Med       Date:  2015-01       Impact factor: 12.137

10.  ER-anchored CRTH2 antagonizes collagen biosynthesis and organ fibrosis via binding LARP6.

Authors:  Shengkai Zuo; Bei Wang; Jiao Liu; Deping Kong; Hui Cui; Yaonan Jia; Chenyao Wang; Xin Xu; Guilin Chen; Yuanyang Wang; Linlin Yang; Kai Zhang; Ding Ai; Jie Du; Yujun Shen; Ying Yu
Journal:  EMBO J       Date:  2021-07-05       Impact factor: 14.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.